KR20230089201A - Novel Streptomyces collinus Inha504 for controlling against plant pathogenic fungi and use thereof - Google Patents
Novel Streptomyces collinus Inha504 for controlling against plant pathogenic fungi and use thereof Download PDFInfo
- Publication number
- KR20230089201A KR20230089201A KR1020210177642A KR20210177642A KR20230089201A KR 20230089201 A KR20230089201 A KR 20230089201A KR 1020210177642 A KR1020210177642 A KR 1020210177642A KR 20210177642 A KR20210177642 A KR 20210177642A KR 20230089201 A KR20230089201 A KR 20230089201A
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- inha504
- streptomyces collinus
- fusarium
- streptomyces
- Prior art date
Links
- 241000145545 Streptomyces collinus Species 0.000 title claims abstract description 32
- 244000000004 fungal plant pathogen Species 0.000 title abstract description 7
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 22
- -1 polyene compounds Chemical class 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 4
- 241000233866 Fungi Species 0.000 claims description 18
- 230000003032 phytopathogenic effect Effects 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 241000223221 Fusarium oxysporum Species 0.000 claims description 8
- 241001208371 Fusarium incarnatum Species 0.000 claims description 6
- 241000228245 Aspergillus niger Species 0.000 claims description 5
- 241000123650 Botrytis cinerea Species 0.000 claims description 5
- 241000222122 Candida albicans Species 0.000 claims description 5
- 241000223211 Curvularia lunata Species 0.000 claims description 5
- 241000427940 Fusarium solani Species 0.000 claims description 5
- 241000233732 Fusarium verticillioides Species 0.000 claims description 5
- 239000001963 growth medium Substances 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229940095731 candida albicans Drugs 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 101100198870 Rhizobium leguminosarum bv. viciae ropB gene Proteins 0.000 claims description 2
- 101100091847 Streptococcus pyogenes serotype M18 (strain MGAS8232) rpoB gene Proteins 0.000 claims description 2
- 241000186361 Actinobacteria <class> Species 0.000 abstract description 10
- 241000187747 Streptomyces Species 0.000 abstract description 6
- 230000000853 biopesticidal effect Effects 0.000 abstract description 5
- 238000005457 optimization Methods 0.000 abstract description 2
- 230000000975 bioactive effect Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 229920001817 Agar Polymers 0.000 description 12
- 239000008272 agar Substances 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 7
- 239000000575 pesticide Substances 0.000 description 7
- 239000001965 potato dextrose agar Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241001446247 uncultured actinomycete Species 0.000 description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 3
- 241000223218 Fusarium Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000001851 biosynthetic effect Effects 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229930000044 secondary metabolite Natural products 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 238000012070 whole genome sequencing analysis Methods 0.000 description 3
- 240000004160 Capsicum annuum Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010070863 Toxicity to various agents Diseases 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 2
- 229960003255 natamycin Drugs 0.000 description 2
- 235000010298 natamycin Nutrition 0.000 description 2
- 239000004311 natamycin Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000005838 Streptomyces K61 (formerly S. griseoviridis) Substances 0.000 description 1
- 241000187218 Streptomyces goshikiensis Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000012458 antifungal assay Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000031902 chemoattractant activity Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 235000020569 organic green tea Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
- A01N63/28—Streptomyces
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Agronomy & Crop Science (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
본 발명은 식물 병원성 진균 제어용 신규 균주 스트렙토마이세스 콜리너스(Streptomyces collinus) Inha504 및 이의 용도에 관한 것이다.The present invention relates to a novel strain Streptomyces collinus Inha504 for controlling plant pathogenic fungi and uses thereof.
미생물 기반 친환경 생물농약의 필요성은 더 이상의 설명이 필요 없을 정도로 절실하다. 현재 생물농약으로는, 바실러스 (Bacillus) 기반의 살충제를 포함한 다양한 미생물 종이 사용되고 있으나, 농업용 작물에 대한 항진균 생물농약으로는 방선균, 특히 스트렙토마이세스 (Streptomyces) 종이 다수를 차지하고 있다.The need for microbial-based eco-friendly biopesticides is so desperate that no further explanation is needed. Currently, as biopesticides, various microbial species, including Bacillus -based insecticides, are used, but as antifungal biopesticides for agricultural crops, actinomycetes, particularly Streptomyces species, occupy the majority.
국내 생물농약 (일명 천연식물보호제) 등록현황 (2012년 12월말 현재)에 따르면, 방선균 기반의 생물 농약으로는 (주)케이아이비씨의 방선균 2종 (스트렙토마이세스 고시키엔시스 더블유와이이324 액제, 스트렙토마이세스 콜롬비엔시스 더블유와이이20 액제)이 등록되어 사용되고 있다. According to the registration status of domestic biological pesticides (aka natural plant protection agents) (as of the end of December 2012), two types of actinomycetes of KIBC Co., Ltd. (Streptomyces goshikiensis WY 324 liquid formulation) are actinomycetes-based biological pesticides. , Streptomyces columbiensis WY 20 liquid) has been registered and used.
국외에서는 더욱 활발하게 방선균 기반 생물농약이 사용되고 있으며, 특히 미국 노보자임의 Streptomyces lydicus WYEC108 (상품명 Actinovate)와 핀란드 Verdera의 Streptomyces K61 (상품명 Mycostop)은 방선균을 주성분으로 하고 있다. 중국의 경우에도 폴리엔계 켄디시신 및 나타마이신을 생산하는 방선균 스트렙토마이세스 (Streptomyces)를 생물농약으로 활용하여 작물의 진균 감염 및 진균 공생 해충을 친환경적으로 제어하고 있다.Actinomyces-based biological pesticides are being used more actively overseas, especially Streptomyces from Novozyme in the US. lydicus WYEC108 (trade name Actinovate) and Streptomyces K61 (trade name Mycostop) from Verdera, Finland have actinomycetes as their main components. In the case of China, the actinomycete Streptomyces , which produces polyene-based Kendicin and Natamycin, is used as a biological pesticide to control fungal infections and fungal symbiotic pests in an eco-friendly manner.
본 발명의 목적은 식물병원성 진균에 대한 항진균 활성을 갖는 스트렙토마이세스 콜리너스(Streptomyces collinus) Inha504 균주(KCTC14683BP) 및 상기 균주 또는 이의 배양액을 유효성분으로 포함하는 식물병원성 진균 방제용 조성물을 제공하는데 있다. An object of the present invention is Streptomyces collinus having antifungal activity against phytopathogenic fungi ( Streptomyces collinus ) Inha504 strain (KCTC14683BP) and to provide a composition for controlling phytopathogenic fungi containing the strain or its culture medium as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 KCTC14683BP로 기탁되고, 식물병원성 진균에 대한 항진균 활성을 갖는 스트렙토마이세스 콜리너스(Streptomyces collinus) Inha504 균주를 제공한다. In order to achieve the above object, the present invention is deposited as KCTC14683BP, and provides a Streptomyces collinus Inha504 strain having antifungal activity against phytopathogenic fungi.
또한, 본 발명은 상기 균주 또는 이의 배양액을 유효성분으로 포함하는 식물병원성 진균 방제용 조성물을 제공한다.In addition, the present invention provides a composition for controlling phytopathogenic fungi comprising the strain or its culture medium as an active ingredient.
본 발명은 식물 병원성 진균 제어용 신규 균주 스트렙토마이세스 콜리너스(Streptomyces collinus) Inha504 및 이의 용도에 관한 것으로, 본 발명에서는 항진균 활성이 우수한 폴리엔 화합물을 생산하는 방선균을 유전체 검색기술로 선별한 후, NGS 기반으로 유전체를 해독하여 해당 생리활성물질의 특성을 분자수준에서 규명하고, 이들 유용 방선균 (혹은 방선균 유래 생리활성물질)을 생물농약으로 실용화하기 위한 배양공정 최적화를 수행하였다. 이에, 본 발명의 스트렙토마이세스 콜리너스(Streptomyces collinus) Inha504 균주는 식물 병원성 진균을 효과적으로 제어하므로 생물농약으로 유용하게 활용될 가능성이 있다.The present invention relates to a novel strain for controlling plant pathogenic fungi, Streptomyces collinus Inha504, and its use. Based on this, the genome was decoded to identify the characteristics of the physiologically active substance at the molecular level, and the cultivation process optimization was performed to commercialize these useful actinomycetes (or physiologically active substances derived from actinomycetes) as biological pesticides. Accordingly, Streptomyces collinus of the present invention ( Streptomyces collinus ) Inha504 strain is likely to be usefully used as a biological pesticide because it effectively controls plant pathogenic fungi.
도 1은 방선균 배양액 샘플들의 항진균 활성을 확인한 결과이다.
도 2는 Streptomyces collinus Inha504 균주의 예상 폴리엔 화합물 생합성 유전자군을 나타낸다.
도 3은 Streptomyces collinus Inha504 균주가 생산할 것으로 예상되는 폴리엔 화합물 구조를 나타낸다.
도 4는 여러 가지 식물병원성 진균에 대한 Streptomyces collinus Inha504 균주의 항진균 활성 결과를 나타낸다.1 is a result of confirming the antifungal activity of actinomycete culture samples.
Figure 2 shows the predicted polyene compound biosynthetic gene group of Streptomyces collinus Inha504 strain.
Figure 3 shows the structure of the polyene compound expected to be produced by the Streptomyces collinus Inha504 strain.
Figure 4 shows the antifungal activity results of the Streptomyces collinus Inha504 strain against various phytopathogenic fungi.
본 발명은 KCTC14683BP로 기탁되고, 식물병원성 진균에 대한 항진균 활성을 갖는 스트렙토마이세스 콜리너스(Streptomyces collinus) Inha504 균주를 제공한다. The present invention is deposited as KCTC14683BP, and has antifungal activity against phytopathogenic fungi Streptomyces collinus ( Streptomyces collinus ) Inha504 strain is provided.
바람직하게는, 상기 균주는 칸디다 알비칸스(Candida albicans), 아스퍼질러스 나이거(Aspergillus niger), 푸자리움 옥시스포럼(Fusarium oxysporum), 푸자리움 솔라니(Fusarium solani), 푸자리움 베르티실리오이드(Fusarium verticillioides), 푸자리움 세미텍툼(Fusarium semitectum), 보트리티스 시네레아(Botrytis cinerea) 및 커부라리아 루나타(Curvularia lunata)로 이루어진 군에서 선택된 어느 하나 이상의 진균에 항진균 활성을 갖을 수 있으나, 이에 제한되는 것은 아니다.Preferably, the strain is Candida albicans, Aspergillus niger , Fusarium oxysporum, Fusarium oxysporum , Fusarium solani , Fusarium verticillioi de ( Fusarium verticillioides ), Fusarium semitectum ( Fusarium semitectum ), Botrytis cinerea ( Botrytis cinerea ) and Curvularia lunata ( Curvularia lunata ) It may have antifungal activity against any one or more fungi selected from the group consisting of , but is not limited thereto.
바람직하게는, 상기 균주는 서열번호 1로 표시되는 16S rRNA 염기서열 또는 서열번호 2로 표시되는 ropB 염기서열을 포함할 수 있으나, 이에 제한되는 것은 아니다.Preferably, the strain may include the 16S rRNA nucleotide sequence represented by SEQ ID NO: 1 or the ropB nucleotide sequence represented by SEQ ID NO: 2, but is not limited thereto.
바람직하게는, 상기 균주는 폴리엔 화합물을 생산할 수 있으며, 보다 바람직하게는, 상기 폴리엔 화합물은 하기 화학식 1로 표시될 수 있으나, 이에 제한되는 것은 아니다.Preferably, the strain may produce a polyene compound, and more preferably, the polyene compound may be represented by Formula 1 below, but is not limited thereto.
[화학식 1][Formula 1]
또한, 본 발명은 상기 균주 또는 이의 배양액을 유효성분으로 포함하는 식물병원성 진균 방제용 조성물을 제공한다.In addition, the present invention provides a composition for controlling phytopathogenic fungi comprising the strain or its culture medium as an active ingredient.
본 발명에 있어, 식물병원성 진균 방제용 조성물은 본 발명에 의한 균주를 유효량 함유하고 농화학적으로 허용 되는 담체를 포함한다. 본 발명에 의한 조성물은 당업계에 공지된 방식의 미생물 농약 제제화 방식에 따라, 예컨대 배양된 균체의 배양액, 동결건조 균체와 전분, 조단백질 및 암석분 등을 포함하도록 분말, 펠렛 또는 과립, 마이크로캡슐 등으로 제형화하여 그대로 사용할 수 있다. 상기 조성물은 표면 활성화제, 비활성 담체, 보존제, 습윤제, 공급 촉진제, 유인제, 캡슐화제, 결합제, 유화제, 염료, U.V. 보호제, 완충제 등 목적 병원균 및 작물에 따라 적용하기 용이한 다른 성분을 부가함으로 수득할 수 있다. 본 발명의 조성물은 적용하기 전에 적당한 양의 물 또는 다른 희석제로 희석을 하여 직접 적용하기에 적합한 형태 또는 농축액 또는 1차 조성물일 수 있다. 항진균성 농도는 특히 농축 또는 직접 사용하거나 하는 것은 특정 제제의 성질, 적용 식물의 종류, 재배 지역의 토양 및 기후 등에 따라 다양할 수 있음은 당업계에 명백히 이해될 것이다.In the present invention, the composition for controlling phytopathogenic fungi contains an effective amount of the strain according to the present invention and an agrochemically acceptable carrier. The composition according to the present invention is prepared according to a method of formulating microbial pesticides known in the art, for example, powder, pellets or granules, microcapsules, etc. It can be formulated and used as is. The composition includes a surface active agent, an inert carrier, a preservative, a wetting agent, a supply promoter, an attractant, an encapsulant, a binder, an emulsifier, a dye, a U.V. It can be obtained by adding other components that are easy to apply according to the target pathogen and crop, such as a protective agent and a buffer. The composition of the present invention may be diluted with an appropriate amount of water or other diluent prior to application and may be in a form suitable for direct application or in a concentrate or primary composition. It will be clear to those skilled in the art that antifungal concentrations, particularly concentrated or used directly, may vary depending on the nature of the particular formulation, the type of plant to be applied, the soil and climate of the growing region, and the like.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시에는 오로지 본 발명을 예시하기 위한 것으로, 본 발명이 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail through examples. These examples are only for exemplifying the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.
<< 실험예Experimental example >>
하기의 실험예들은 본 발명에 따른 각각의 실시예에 공통적으로 적용되는 실험예를 제공하기 위한 것이다.The following experimental examples are intended to provide experimental examples commonly applied to each embodiment according to the present invention.
1. 샘플 수집 및 분리1. Sample collection and separation
항진균 활성을 갖는 균주를 선별하기 위해 한국생명공학연구원의 김창진 박사님 연구실로부터 2419개의 방선균 배양액을 이용하여 진균에 대한 저해환 실험을 실시하였다. 그 중 2009년 보성의 유기농 녹차밭에서 동정한 Streptomyces collinus Inha504(AN090291) 균주를 분양받았다. 생물학적 특징으로는 Fusarium oxysporum (KCTC 46453), Candida albicans (ATCC 14053)에 대한 항진균 활성을 갖는 균주로 확인하였다.In order to select strains with antifungal activity, an antifungal test was conducted using 2419 actinomycete cultures from Dr. Kim Chang-jin's laboratory at the Korea Research Institute of Bioscience and Biotechnology. Among them, a Streptomyces collinus Inha504 (AN090291) strain identified from an organic green tea field in Boseong in 2009 was distributed. Biological characteristics include Fusarium oxysporum (KCTC 46453), Candida It was confirmed as a strain having antifungal activity against albicans (ATCC 14053).
2. 성장 조건 및 배지2. Growth conditions and media
Streptomyces collinus Inha504(AN090291) 균주는 M3 agar (soluble starch 20 g/L, agar 20 g/L, soytone 10 g/L, glucose 10 g/L, CaCO3 3 g/L, FeSO4·7H2O 0.2 g/L)에서 30℃, 7일간 고체 정치배양을 통해 전배양을 실시하고 GSS agar (soybean flour 25 g/L, glucose 20 g/L, soluble starch 10 g/L, yeast extract 4 g/L, NaCl 2 g/L, CaCO3 2 g/L, Beef extract 1 g/L, K2HPO4 0.25 g/L)에서 30℃, 7일간 고체 정치배양을 통해 생산배양을 실시한다. 식물병원성 7종[Fusarium oxysporum (KACC 40051), Fusarium solani (KACC 44891), Fusarium verticillioides (KCTC 16672). Fusarium semitectum (KCTC 6065), Botrytis cinerea (KACC 40574), Curvularia lunata (KACC 40861), Aspergillus niger (KCTC46204)]은 PDA (potato starch 4 g/L, glucose 2 g/L, agar 15 g/L)에서 30℃, 3~7일간 고체 정치배양을 한다. Candida albicans (ATCC 14053) 균주는 YM agar (yeast extraction 3 g/L, malt extraction 3 g/L, peptone 5 g/L, glucose 10 g/L, agar 20 g/L)에서 30℃, 220rpm, 12시간 동안 진탕 배양을 한다. Streptomyces collinus Inha504 (AN090291) strain is M3 agar (soluble starch 20 g/L, agar 20 g/L, soytone 10 g/L, glucose 10 g/L, CaCO 3 3 g/L, FeSO 4 7H 2 O 0.2 g/L) at 30℃ for 7 days, pre-culture was performed through solid static culture, and GSS agar (soybean flour 25 g/L, glucose 20 g/L, soluble starch 10 g/L, yeast extract 4 g/L, NaCl 2 g/L, CaCO 3 2 g/L, Beef extract 1 g/L, K 2 HPO 4 0.25 g/L) at 30° C. for 7 days, and production culture is performed through solid stationary culture. Plant pathogenic 7 species [ Fusarium oxysporum (KACC 40051), Fusarium solani (KACC 44891), Fusarium verticillioides (KCTC 16672). Fusarium semitectum (KCTC 6065), Botrytis cinerea (KACC 40574) , Curvularia lunata (KACC 40861), Aspergillus niger (KCTC46204)] is subjected to solid static culture at 30℃ for 3 to 7 days in PDA (potato starch 4 g/L, glucose 2 g/L, agar 15 g/L). Candida albicans (ATCC 14053) strain was grown on YM agar (yeast extraction 3 g/L, malt extraction 3 g/L, peptone 5 g/L, glucose 10 g/L, agar 20 g/L) at 30℃, 220 rpm, 12 hours. culture while shaking.
3. 플레이트 대면 분석을 통한 항진균 분석3. Antifungal assay by plate-to-plate assay
고체 정치배양을 통해 생산배양을 실시한 GSS agar plate에서 지름 0.5cm의 원형 agar plug를 준비한다. 저해활성을 보고자 하는 곰팡이가 포함된 PDA agar plate을 준비하기 위해 고체 정치배양을 한 곰팡이의 포자를 2 cm × 2 cm 크기 정도로 긁어 1% 아가로스젤(agarose gel)과 섞어준 뒤 PDA agar plate 위를 덮도록 부어주고 30분간 굳게 둔다. 곰팡이가 포함된 PDA agar plate 위에 원형 agar plug를 적절한 위치에 올린 후 30℃, 3~7일간 고체 정치배양을 하면서 저해환을 관찰하고 이 크기를 기록한다.Prepare a circular agar plug with a diameter of 0.5 cm from the GSS agar plate where production culture was performed through solid stationary culture. In order to prepare a PDA agar plate containing the fungus to be tested for inhibitory activity, scrape the spores of the fungus that had undergone solid static culture to a size of 2 cm × 2 cm, mix them with 1% agarose gel, and place them on the PDA agar plate. Pour over to cover and set aside for 30 minutes. After placing the circular agar plug on the PDA agar plate containing the fungus in an appropriate position, observe the inhibition ring while performing solid stationary culture at 30 ° C for 3 to 7 days and record the size.
4. 전체 게놈 서열분석 및 클러스터 예측4. Whole Genome Sequencing and Cluster Prediction
Streptomyces collinus Inha504(AN090291) 균주의 전체 염기서열은 PacBio RSII, Illumina platform and De novo assembly를 이용하여 한국 macrogen에 외주를 맡겨 분석하였다. 전체 염기서열 속 이차대사산물의 생합성 유전자 클러스터(biosynthetic gene cluster)는 antiSMASH bacterial version 5.0((https://antismash.secondarymetabolites.org/#!/start)을 이용하여 분석하였다.The entire sequence of Streptomyces collinus Inha504 (AN090291) strain was outsourced to Korean macrogen for analysis using PacBio RSII, Illumina platform and De novo assembly. The biosynthetic gene cluster of secondary metabolites in the entire sequence was analyzed using antiSMASH bacterial version 5.0 ((https://antismash.secondarymetabolites.org/#!/start).
5. 온실 조건하에서 식물 비료로서의 적용 가능성 평가 5. Evaluation of applicability as plant fertilizer under greenhouse conditions
수원의 한국식물환경연구소에 용역의뢰 후 확인실험을 진행하였다(pot test).After requesting a service from the Korea Plant Environment Research Institute in Suwon, a confirmation experiment was conducted (pot test).
가. 대상병해: 시들음병(Fusarium oxysporium, KACC40051) go. Target disease: Wilt disease ( Fusarium oxysporium , KACC40051)
나. 시험작물: 고추(독야청청), 토마토(슈퍼도태랑), 딸기(설향)me. Test crops: Red pepper (Dokyacheong), Tomato (Superculant), Strawberry (Seolhyang)
※ 대상병해 발생상황※ Target disease occurrence status
농촌진흥청 국립농업과학원 농업생물부부터 대상 병원균인 시들음병균 (Fusarium oxysporium)을 분양받아 PDA(Potato Dextrose Agar) 배지에 배양하여 접종원을 준비하였으며, 모종에 접종하여 시들음병 발생을 유도하였다. The target pathogen, Fusarium oxysporium , was distributed from the Department of Agricultural Biology, National Institute of Agricultural Sciences, Rural Development Administration, and the inoculum was prepared by culturing on PDA (Potato Dextrose Agar) medium, and seedlings were inoculated to induce the occurrence of wilt disease.
다. 처리내용 : 토양관주처리 - 희석한 배양액 1L/m2 (희석배수 500배), 처리 폿트 수 : 5개 all. Details of treatment: soil drench treatment - diluted culture medium 1L/m 2 (dilution factor: 500 times), number of treatment pots: 5
라. 경종개요 : 재배양식 (시설재배, 폿트재배), 폿트크기 : 지름 6cm la. Seedling outline: Cultivation type (facility cultivation, pot cultivation), pot size: 6cm in diameter
마. 조사방법 및 판정기준 : 약효시험 (이병주수, 약제처리 7일 후 작물별 병발생 정도), 약해시험 (외관상 약해유무, 약제처리 3, 5, 7일 후 외관확인)mind. Investigation method and criterion: Drug efficacy test (number of sicknesses, degree of disease occurrence by crop after 7 days of drug treatment), drug toxicity test (appearance of drug damage, appearance check after 3, 5, or 7 days of drug treatment)
<< 실시예Example 1> 항진균 활성을 갖는 1> having antifungal activity StreptomycesStreptomyces collinuscollinus Inha504(AN090291)Inha504 (AN090291) 방선균 actinomycetes 선별 Selection
KRIBB의 김창진 박사님 실험실로부터 방선균 배양액을 분주 받아 항진균 활성을 확인할 때 자주 사용되는 C. albicans와 식물병원성 진균인 F. oxysporum을 이용해 항진균 활성 비교실험을 진행하였다.An antifungal activity comparison experiment was conducted using C. albicans , which is often used to check antifungal activity, and F. oxysporum , a phytopathogenic fungus, by receiving aliquots of actinomycete cultures from Dr. Kim Chang-jin's laboratory at KRIBB.
2419개의 샘플들 중 149개의 샘플에서 억제 영역(inhibition zone)을 보이며 항진균 활성을 확인하였다(도 1).Antifungal activity was confirmed by showing an inhibition zone in 149 samples out of 2419 samples (FIG. 1).
16s rRNA sequence, RNA polymerase B 등 특정 유전자의 서열 비교를 통해 신규 균주라고 판단되는 Streptomyces collinus Inha504(AN090291) 균주를 선별하였다. Streptomyces collinus Inha504 (AN090291) strain, which was considered a new strain, was selected through sequence comparison of specific genes such as 16s rRNA sequence and RNA polymerase B.
<< 실시예Example 2> 2> StreptomycesStreptomyces collinuscollinus Inha504Inha504 (AN090291) 균주 전체 게놈 서열분석과 항진균 활성물질의 특성 분석(AN090291) Whole genome sequencing of strain and characterization of antifungal active substances
전체 게놈 서열분석을 통해 Streptomyces 계열의 신규 균주임을 확인하였다(표 1). Streptomyces through whole-genome sequencing It was confirmed that it was a new strain of the series (Table 1).
antiSMASH 프로그램을 이용하여, 총 36개의 영역에서 이차대사산물을 만드는 클러스터(cluster)를 찾아냈고, 34번째 영역에서 폴리엔 화합물(polyene compound)을 만들어내는 생합성 유전자군으로 예측되었다(도 2). 이는 기존에 알려진 나타마이신 클러스터(natamycin cluster)와 높은 유사성을 보였다(도 3).Using the antiSMASH program, clusters producing secondary metabolites were found in a total of 36 regions, and the 34th region was predicted to be a biosynthetic gene group producing polyene compounds (FIG. 2). This showed high similarity with the previously known natamycin cluster (Fig. 3).
<< 실시예Example 3> 항진균 활성 확인 3> Confirmation of antifungal activity
아래의 여러 가지 식물병원성 진균에 대한 항진균 활성을 확인한 결과, 확인한 모든 진균에서 활성을 확인하였다(도 4). As a result of confirming the antifungal activity against various phytopathogenic fungi below, the activity was confirmed in all the confirmed fungi (FIG. 4).
Fusarium oxysporum (KACC 40051), Fusarium solani (KACC 44891), Fusarium verticillioides (KCTC 16672). Fusarium semitectum (KCTC 6065), Botrytis cinerea (KACC 40574), Curvularia lunata (KACC 40861), Aspergillus niger (KCTC46204). Fusarium oxysporum (KACC 40051), Fusarium solani (KACC 44891), Fusarium verticillioides (KCTC 16672). Fusarium semitectum (KCTC 6065), Botrytis cinerea (KACC 40574) , Curvularia lunata (KACC 40861), Aspergillus niger (KCTC46204).
<< 실시예Example 4> 미생물제제로서의 가능성 확인하기 위해 화분 수준에서 항진균 활성확인 4> Confirmation of antifungal activity at pollen level to confirm potential as a microbial agent
한국식물환경연구소(수원)에 용역을 의뢰하고 진행하였다. 약효시험의 결과, 고추(50.1%), 딸기(53.9%), 토마토(63.6%)의 방제율이 확인되었다. 약해시험의 결과, Streptomyces collinus Inha504(AN090291)의 배양액이 식물에 해를 끼치지 않음을 확인하였다(표 2).The Korea Plant Environment Research Institute (Suwon) commissioned the service and proceeded. As a result of the drug efficacy test, the control rates of red pepper (50.1%), strawberry (53.9%), and tomato (63.6%) were confirmed. As a result of the drug toxicity test, it was confirmed that the culture solution of Streptomyces collinus Inha504 (AN090291) did not harm the plants (Table 2).
이상으로, 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항과 그것들의 등가물에 의해서 정의된다고 할 것이다.In the above, specific parts of the present invention have been described in detail, and for those skilled in the art, these specific descriptions are only preferred embodiments, and the scope of the present invention is not limited thereby. It will be clear. Accordingly, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
<110> INHA-INDUSTRY PARTNERSHIP INSTITUTE <120> Novel Streptomyces collinus Inha504 for controlling against plant pathogenic fungi and use thereof <130> ADP-2021-0518 <160> 2 <170> KopatentIn 2.0 <210> 1 <211> 1514 <212> RNA <213> Streptomyces collinus Inha504 <400> 1 agagtttgat cctggctcag gacgaacgct ggcggcgtgc ttaacacatg caagtcgaac 60 gatgaaccac ttcggtgggg attagtggcg aacgggtgag taacacgtgg gcaatctgcc 120 cttcactctg ggacaagccc tggaaacggg gtctaatacc ggatatgagc ctccaccgca 180 tggtggaggc tgtaaagctc cggcggtgaa ggatgagccc gcggcctatc agcttgttgg 240 tgaggtaatg gctcaccaag gcgacgacgg gtagccggcc tgagagggcg accggccaca 300 ctgggactga gacacggccc agactcctac gggaggcagc agtggggaat attgcacaat 360 gggcgaaagc ctgatgcagc gacgccgcgt gagggatgac ggccttcggg ttgtaaacct 420 ctttcagcag ggaagaagcg aaagtgacgg tacctgcaga agaagcgccg gctaactacg 480 tgccagcagc cgcggtaata cgtagggcgc aagcgttgtc cggaattatt gggcgtaaag 540 agctcgtagg cggcttgtca cgtcgattgt gaaagcccga ggcttaacct cgggtctgca 600 gtcgatacgg gctagctaga gtgtggtagg ggagatcgga attcctggtg tagcggtgaa 660 atgcgcagat atcaggagga acaccggtgg cgaaggcgga tctctgggcc attactgacg 720 ctgaggagcg aaagcgtggg gagcgaacag gattagatac cctggtagtc cacgccgtaa 780 acggtgggaa ctaggtgttg gcgacattcc acgtcgtcgg tgccgcagct aacgcattaa 840 gttccccgcc tggggagtac ggccgcaagg ctaaaactca aaggaattga cgggggcccg 900 cacaagcggc ggagcatgtg gcttaattcg acgcaacgcg aagaacctta ccaaggcttg 960 acatacaccg gaaacgtctg gagacaggcg cccccttgtg gtcggtgtac aggtggtgca 1020 tggctgtcgt cagctcgtgt cgtgagatgt tgggttaagt cccgcaacga gcgcaaccct 1080 tgttctgtgt tgccagcatg cccttcgggg tgatggggac tcacaggaga ccgccggggt 1140 caactcggag gaaggtgggg acgacgtcaa gtcatcatgc cccttatgtc ttgggctgca 1200 cacgtgctac aatggccggt acaatgagct gcgataccgt gaggtggagc gaatctcaaa 1260 aagccggtct cagttcggat tggggtctgc aactcgaccc catgaagtcg gagtcgctag 1320 taatcgcaga tcagcattgc tgcggtgaat acgttcccgg gccttgtaca caccgcccgt 1380 cacgtcacga aagttggtaa cacccgaagc cggtggccca accccttgtg ggagggagct 1440 gtcgaaggtg ggactagcga ttgggacgaa gtcgtaacaa ggtagccgta ccggaaggtg 1500 cggctggatc acct 1514 <210> 2 <211> 3486 <212> DNA <213> Streptomyces collinus Inha504 <400> 2 ttggccgcct cgcgcaacgc ctcgaccgcg aatacgaaca acggcgccag caccgccccg 60 ctgcgcatct cctttgcaaa gatcaaggag cctctcgagg ttccgaacct gctcgcgctg 120 cagaccgaga gcttcgactg gctgctcggc aacaccgcct ggcagagtcg ggtcgaggag 180 gctcttgaga acggtcagga cgtccccacc aagtccggtc tggaggagat cttcgaggag 240 atctccccga tcgaggactt ctccgggtcg atgtccctga ccttccggga ccaccgcttc 300 gagccgccga agaactccat cgacgagtgc aaggaccgcg acttcacgta cgccgccccg 360 ctcttcgtca ccgccgagtt caccaataac gagaccggtg agatcaagtc ccagacggtc 420 ttcatgggcg acttcccgct catgacgaac aagggcacct tcgtcatcaa cggcaccgag 480 cgtgtcgtgg tgtctcagct ggtccgttcc cccggtgtct acttcgattc ctcgatcgac 540 aagacgtccg acaaggacat cttctccgcc aagatcatcc cgtcccgggg tgcctggctg 600 gagatggaga tcgacaagcg tgacatggtc ggtgtccgca tcgaccgcaa gcgcaagcag 660 tcggtcaccg tgctgctgaa ggcgctcggc tggacgaccg agcagatcct cgaggagttc 720 ggcgactacg agtcgatgcg cgccaccctg gagaaggacc acacccaggg ccaggacgac 780 gcgctgctcg acatctaccg caagctgcgt ccgggcgagc cccccacgcg tgaggccgcg 840 cagacgctgc tcgagaacct gtacttcaac cccaagcgct acgacctggc caaggtcggc 900 cgctacaagg tcaacaagaa gctgggcgcc gacgctccgc tcgacgcggg catcctgacc 960 gtcgaggaca tcatctcgac gatcaagtac ctggtgcagc tgcacgccgg cgagaccgag 1020 accaccggcg acaacggcga cagcatcgtt gtcgagacgg acgacatcga ccacttcggc 1080 aaccggcgcc tgcgcagcgt cggcgagctg atccagaacc aggtccgtac gggtctcgcc 1140 cgtatggagc gcgtcgtgcg cgagcgcatg acgacccagg acgtcgaggc gatcacgccg 1200 cagaccctga tcaacatccg gccggtcgtc gcctccatca aggagttctt cggcaccagc 1260 cagctgtcgc agttcatgga ccagaacaac ccgctgtcgg gtctcaccca caagcgccgc 1320 ctgtcggccc ttggcccggg tggtctctcc cgtgagcggg ccggcttcga ggtccgtgac 1380 gtgcacccct cgcactacgg ccgcatgtgc ccgatcgaga cgcccgaagg cccgaacatc 1440 ggtctgatcg gctcgctcgc ctcctacggc cgggtcaacg cgttcggttt cgtcgagacc 1500 ccgtaccgca aggtcaacga cggccaggtc accgacgagg tcgactacct gaccgccgac 1560 gaggaggacc gcttcgtcat cgcgcaggcc aacgccacgc tcaacgacga actgcggttc 1620 gccgaggcgc gtgtcctggt ccgccgccgt ggcggtgagg tcgactacgt cagccccgag 1680 gacgtcgact acatggacgt ctcgccgcgc cagatggtgt cggtcgcgac cgccatgatc 1740 ccgttcctcg agcacgacga cgccaaccgt gccctcatgg gcgcgaacat gatgcgccag 1800 gccgtgccgc tcatcaagtc cgaggcgccg ctcgtcggca ccggcatgga gtaccgctcc 1860 gcggtcgacg ccggcgacgt ggtcaaggcc gagaaggacg gtgtggtcca ggaggtctcc 1920 gcggactaca tcaccacggc gaacgacgac ggcacgtaca tcacgtaccg cctgcacaag 1980 ttctcccggt ccaaccaggg cacctcggtc aaccagaagg tcgtcgtcga cgagggcgac 2040 cggatcatca cgggccaggt gctcgcggac ggtccggcca ccgagaacgg cgagatggcc 2100 ctgggcaaga acctgctcgt ggcgttcatg ccgtgggagg gtcacaacta cgaggacgcg 2160 atcatcctgt cgcagcgcct cgtgcaggac gacgtcctct cctcgatcca catcgaggag 2220 cacgaggtcg acgcccgtga caccaagctg ggccccgagg agatcacccg ggacatcccg 2280 aacgtctccg aggaggtcct cgccgacctc gacgagcgcg gcatcatccg tatcggtgcc 2340 gaggtcgtcg ccggtgacat cctcgtcggc aaggtcacgc ccaagggtga gaccgagctg 2400 acaccggagg agcgcctgct gcgcgcgatc ttcggtgaga aggcccgtga ggtccgtgac 2460 acctccctga aggtgccgca cggcgagatc ggcaaggtca tcggcgtccg cgtcttcgac 2520 cgcgaggagg gcgacgagct gccgccgggc gtgaaccagc tggtccgcgt ctacgtcgcg 2580 cagaagcgca agatcaccga cggtgacaag ctcgccggcc gtcacggcaa caagggtgtc 2640 atctccaaga tcctgccgat cgaggacatg ccgttcctgg aggacggcac cccggtcgac 2700 atcatcctca acccgctggg tgtgccgtcc cgaatgaacc cgggacaggt cctggagatc 2760 cacctcggct ggctcgccag ccgtggctgg gacgtctccg gtctcgccga cgagtgggcg 2820 cagcgcctgc aggtcatcgg cgccgaccag gtcgacccgg gcacgaacgt cgcgaccccc 2880 gtcttcgacg gtgcgcgcga ggacgagctc gcgggtctgc tgcagcacac catcccgaac 2940 cgcgacggcg agcgcatggt gctcccgtcc ggcaaggcgc ggctgttcga cggccgcagc 3000 ggtgagccgt tcccggagcc gatctcggtc ggctacatgt acatcctgaa gctgcaccac 3060 ctggtcgacg acaagctgca cgcccgctcg accggtccgt actcgatgat cacccagcag 3120 ccgctgggtg gtaaggcgca gttcggtggc cagcggttcg gcgagatgga ggtgtgggcc 3180 ctcgaggcct acggcgccgc ctacgcgctg caggagctgc tgacgatcaa gtccgacgac 3240 gtgaccggcc gcgtgaaggt ctacgaggcc atcgtcaagg gcgagaacat ccccgagccc 3300 ggcatccccg agtccttcaa ggtgctcatc aaggagatgc agtcgctctg cctgaacgtg 3360 gaggtgctgt ccagcgacgg tatgtccatc gagatgcgcg acaccgacga ggacgtcttc 3420 cgcgctgcgg aggagctcgg tatcgacctg tcccggcgcg agccgagcag cgtcgaagag 3480 gtctga 3486 <110> INHA-INDUSTRY PARTNERSHIP INSTITUTE <120> Novel Streptomyces collinus Inha504 for controlling against plant pathogenic fungi and their use <130> ADP-2021-0518 <160> 2 <170> KopatentIn 2.0 <210> 1 <211> 1514 <212> RNA <213> Streptomyces collinus Inha504 <400> 1 agagtttgat cctggctcag gacgaacgct ggcggcgtgc ttaacacatg caagtcgaac 60 gatgaaccac ttcggtgggg attagtggcg aacgggtgag taacacgtgg gcaatctgcc 120 cttcactctg ggacaagccc tggaaacggg gtctaatacc ggatatgagc ctccaccgca 180 tggtggaggc tgtaaagctc cggcggtgaa ggatgagccc gcggcctatc agcttgttgg 240 tgaggtaatg gctcaccaag gcgacgacgg gtagccggcc tgagagggcg accggccaca 300 ctgggactga gacacggccc agactcctac gggaggcagc agtggggaat attgcacaat 360 gggcgaaagc ctgatgcagc gacgccgcgt gagggatgac ggccttcggg ttgtaaacct 420 ctttcagcag ggaagaagcg aaagtgacgg tacctgcaga agaagcgccg gctaactacg 480 tgccagcagc cgcggtaata cgtagggcgc aagcgttgtc cggaattatt gggcgtaaag 540 agctcgtagg cggcttgtca cgtcgattgt gaaagcccga ggcttaacct cgggtctgca 600 gtcgatacgg gctagctaga gtgtggtagg ggagatcgga attcctggtg tagcggtgaa 660 atgcgcagat atcaggagga acaccggtgg cgaaggcgga tctctgggcc attactgacg 720 ctgaggagcg aaagcgtggg gagcgaacag gattagatac cctggtagtc cacgccgtaa 780 acggtgggaa ctaggtgttg gcgacattcc acgtcgtcgg tgccgcagct aacgcattaa 840 gttccccgcc tggggagtac ggccgcaagg ctaaaactca aaggaattga cgggggcccg 900 cacaagcggc ggagcatgtg gcttaattcg acgcaacgcg aagaacctta ccaaggcttg 960 acatacaccg gaaacgtctg gagacaggcg cccccttgtg gtcggtgtac aggtggtgca 1020 tggctgtcgt cagctcgtgt cgtgagatgt tgggttaagt cccgcaacga gcgcaaccct 1080 tgttctgtgt tgccagcatg cccttcgggg tgatggggac tcacaggaga ccgccggggt 1140 caactcggag gaaggtgggg acgacgtcaa gtcatcatgc cccttatgtc ttgggctgca 1200 cacgtgctac aatggccggt acaatgagct gcgataccgt gaggtggagc gaatctcaaa 1260 aagccggtct cagttcggat tggggtctgc aactcgaccc catgaagtcg gagtcgctag 1320 taatcgcaga tcagcattgc tgcggtgaat acgttcccgg gccttgtaca caccgcccgt 1380 cacgtcacga aagttggtaa cacccgaagc cggtggccca accccttgtg ggagggagct 1440 gtcgaaggtg ggactagcga ttgggacgaa gtcgtaacaa ggtagccgta ccggaaggtg 1500 cggctggatc acct 1514 <210> 2 <211> 3486 <212> DNA <213> Streptomyces collinus Inha504 <400> 2 ttggccgcct cgcgcaacgc ctcgaccgcg aatacgaaca acggcgccag caccgccccg 60 ctgcgcatct cctttgcaaa gatcaaggag cctctcgagg ttccgaacct gctcgcgctg 120 cagaccgaga gcttcgactg gctgctcggc aacaccgcct ggcagagtcg ggtcgaggag 180 gctcttgaga acggtcagga cgtccccacc aagtccggtc tggaggagat cttcgaggag 240 atctccccga tcgaggactt ctccgggtcg atgtccctga ccttccggga ccaccgcttc 300 gagccgccga agaactccat cgacgagtgc aaggaccgcg acttcacgta cgccgccccg 360 ctcttcgtca ccgccgagtt caccaataac gagaccggtg agatcaagtc ccagacggtc 420 ttcatgggcg acttcccgct catgacgaac aagggcacct tcgtcatcaa cggcaccgag 480 cgtgtcgtgg tgtctcagct ggtccgttcc cccggtgtct acttcgattc ctcgatcgac 540 aagacgtccg acaaggacat cttctccgcc aagatcatcc cgtcccgggg tgcctggctg 600 gagatggaga tcgacaagcg tgacatggtc ggtgtccgca tcgaccgcaa gcgcaagcag 660 720 ggcgactacg agtcgatgcg cgccaccctg gagaaggacc acacccaggg ccaggacgac 780 gcgctgctcg acatctaccg caagctgcgt ccgggcgagc cccccacgcg tgaggccgcg 840 cagacgctgc tcgagaacct gtacttcaac cccaagcgct acgacctggc caaggtcggc 900 cgctacaagg tcaacaagaa gctgggcgcc gacgctccgc tcgacgcggg catcctgacc 960 gtcgaggaca tcatctcgac gatcaagtac ctggtgcagc tgcacgccgg cgagaccgag 1020 accaccggcg acaacggcga cagcatcgtt gtcgagacgg acgacatcga ccacttcggc 1080 aaccggcgcc tgcgcagcgt cggcgagctg atccagaacc aggtccgtac gggtctcgcc 1140 cgtatggagc gcgtcgtgcg cgagcgcatg acgacccagg acgtcgaggc gatcacgccg 1200 cagaccctga tcaacatccg gccggtcgtc gcctccatca aggagttctt cggcaccagc 1260 cagctgtcgc agttcatgga ccagaacaac ccgctgtcgg gtctcaccca caagcgccgc 1320 ctgtcggccc ttggcccggg tggtctctcc cgtgagcggg ccggcttcga ggtccgtgac 1380 gtgcacccct cgcactacgg ccgcatgtgc ccgatcgaga cgcccgaagg cccgaacatc 1440 ggtctgatcg gctcgctcgc ctcctacggc cgggtcaacg cgttcggttt cgtcgagacc 1500 ccgtaccgca aggtcaacga cggccaggtc accgacgagg tcgactacct gaccgccgac 1560 gaggaggacc gcttcgtcat cgcgcaggcc aacgccacgc tcaacgacga actgcggttc 1620 gccgaggcgc gtgtcctggt ccgccgccgt ggcggtgagg tcgactacgt cagccccgag 1680 gacgtcgact acatggacgt ctcgccgcgc cagatggtgt cggtcgcgac cgccatgatc 1740 ccgttcctcg agcacgacga cgccaaccgt gccctcatgg gcgcgaacat gatgcgccag 1800 gccgtgccgc tcatcaagtc cgaggcgccg ctcgtcggca ccggcatgga gtaccgctcc 1860 gcggtcgacg ccggcgacgt ggtcaaggcc gagaaggacg gtgtggtcca ggaggtctcc 1920 gcggactaca tcaccacggc gaacgacgac ggcacgtaca tcacgtaccg cctgcacaag 1980 ttctcccggt ccaaccaggg cacctcggtc aaccagaagg tcgtcgtcga cgagggcgac 2040 cggatcatca cgggccaggt gctcgcggac ggtccggcca ccgagaacgg cgagatggcc 2100 ctgggcaaga acctgctcgt ggcgttcatg ccgtgggagg gtcacaacta cgaggacgcg 2160 atcatcctgt cgcagcgcct cgtgcaggac gacgtcctct cctcgatccca catcgaggag 2220 cacgaggtcg acgcccgtga caccaagctg ggccccgagg agatcacccg ggacatcccg 2280 aacgtctccg aggaggtcct cgccgacctc gacgagcgcg gcatcatccg tatcggtgcc 2340 gaggtcgtcg ccggtgacat cctcgtcggc aaggtcacgc ccaagggtga gaccgagctg 2400 acaccggagg agcgcctgct gcgcgcgatc ttcggtgaga aggcccgtga ggtccgtgac 2460 acctccctga aggtgccgca cggcgagatc ggcaaggtca tcggcgtccg cgtcttcgac 2520 cgcgaggagg gcgacgagct gccgccgggc gtgaaccagc tggtccgcgt ctacgtcgcg 2580 cagaagcgca agatcaccga cggtgacaag ctcgccggcc gtcacggcaa caagggtgtc 2640 atctccaaga tcctgccgat cgaggacatg ccgttcctgg aggacggcac cccggtcgac 2700 atcatcctca acccgctggg tgtgccgtcc cgaatgaacc cgggacaggt cctggagatc 2760 cacctcggct ggctcgccag ccgtggctgg gacgtctccg gtctcgccga cgagtgggcg 2820 cagcgcctgc aggtcatcgg cgccgaccag gtcgacccgg gcacgaacgt cgcgaccccc 2880 gtcttcgacg gtgcgcgcga ggacgagctc gcgggtctgc tgcagcacac catcccgaac 2940 cgcgacggcg agcgcatggt gctcccgtcc ggcaaggcgc ggctgttcga cggccgcagc 3000 ggtgagccgt tcccggagcc gatctcggtc ggctacatgt acatcctgaa gctgcaccac 3060 ctggtcgacg acaagctgca cgcccgctcg accggtccgt actcgatgat cacccagcag 3120 ccgctgggtg gtaaggcgca gttcggtggc cagcggttcg gcgagatgga ggtgtgggcc 3180 ctcgaggcct acggcgccgc ctacgcgctg caggagctgc tgacgatcaa gtccgacgac 3240 gtgaccggcc gcgtgaaggt ctacgaggcc atcgtcaagg gcgagaacat ccccgagccc 3300 ggcatccccg agtccttcaa ggtgctcatc aaggagatgc agtcgctctg cctgaacgtg 3360 gaggtgctgt ccagcgacgg tatgtccatc gagatgcgcg acaccgacga ggacgtcttc 3420 cgcgctgcgg aggagctcgg tatcgacctg tcccggcgcg agccgagcag cgtcgaagag 3480 gtctga 3486
Claims (6)
[화학식 1]
According to claim 4, wherein the polyene compound is Streptomyces collinus, characterized in that represented by the formula (1) ( Streptomyces collinus ) Inha504 strain.
[Formula 1]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210177642A KR102590009B1 (en) | 2021-12-13 | 2021-12-13 | Novel Streptomyces collinus Inha504 for controlling against plant pathogenic fungi and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210177642A KR102590009B1 (en) | 2021-12-13 | 2021-12-13 | Novel Streptomyces collinus Inha504 for controlling against plant pathogenic fungi and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230089201A true KR20230089201A (en) | 2023-06-20 |
KR102590009B1 KR102590009B1 (en) | 2023-10-16 |
Family
ID=86995421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210177642A KR102590009B1 (en) | 2021-12-13 | 2021-12-13 | Novel Streptomyces collinus Inha504 for controlling against plant pathogenic fungi and use thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102590009B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100512331B1 (en) | 2002-12-04 | 2005-09-05 | 경상남도 | Preparation of natamycin from Streptomyces natalensis |
KR100523264B1 (en) * | 2003-09-05 | 2005-10-24 | 재단법인한국간연구재단 | Novel streptomyces sp. producing antibacterial and antifungal agent |
KR101423663B1 (en) * | 2012-11-16 | 2014-07-25 | 고려대학교 산학협력단 | Streptomyces mauvecolor strain effective against plant pathogenic fungi and derivative rimocidin antibiotic produced therefrom |
-
2021
- 2021-12-13 KR KR1020210177642A patent/KR102590009B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100512331B1 (en) | 2002-12-04 | 2005-09-05 | 경상남도 | Preparation of natamycin from Streptomyces natalensis |
KR100523264B1 (en) * | 2003-09-05 | 2005-10-24 | 재단법인한국간연구재단 | Novel streptomyces sp. producing antibacterial and antifungal agent |
KR101423663B1 (en) * | 2012-11-16 | 2014-07-25 | 고려대학교 산학협력단 | Streptomyces mauvecolor strain effective against plant pathogenic fungi and derivative rimocidin antibiotic produced therefrom |
Non-Patent Citations (1)
Title |
---|
Journal de Mycologie Médicale, Vol.28, pp.462-468(2018.09.) * |
Also Published As
Publication number | Publication date |
---|---|
KR102590009B1 (en) | 2023-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101291915B1 (en) | Bacillus amyloliquefaciens GYL4 effective against plant pathogenic fungi and method for preparing antibiotics using the same | |
KR101845708B1 (en) | New microorganism Bacillus velezensis YP2 or microbial agent comprising the same | |
US11332709B2 (en) | Strain of Pseudomonas putida and its use in the control of diseases caused by bacteria and fungi in plants | |
KR101524651B1 (en) | Composition for plant disease control containing Streptomyces griseus S4-7' or its culture fluid as an active ingredient | |
US20230087802A1 (en) | Bacillus subtilis jck-1398 strain inducing resistance in various plants, and composition and method for controlling pine wilt disease by using same | |
KR101183538B1 (en) | Novel paenibacillus polymyxa and microorganism agent comprising the strains for preventing phytophtora capsici of plants | |
Türkölmez et al. | Clonostachys rosea Strain ST1140: An endophytic plant-growth-promoting fungus, and its potential use in seedbeds with wheat-grain substrate | |
KR20080064297A (en) | Fungus making process for mold prevent of plant | |
KR102313936B1 (en) | Novel Streptomyces having various biological activity and use thereof | |
KR20100085764A (en) | A novel arthrobacter sp. and biopesticide containing the strain for extermination of anthracnose | |
KR102590009B1 (en) | Novel Streptomyces collinus Inha504 for controlling against plant pathogenic fungi and use thereof | |
Emayavarman et al. | Antifungal efficacy and growth promotion by Trichoderma virens TRI 37 and Bacillus amyloloiquefaciens (VB7) against Macrophomina phaseolina-the maize charcoal rot pathogen | |
KR102590008B1 (en) | Novel Streptomyces javensis Inha503 for controlling against plant pathogenic fungi and use thereof | |
KR102313937B1 (en) | Novel Streptomyces for controlling against plant pathogenic fungi and use thereof | |
KR101953835B1 (en) | Aspergillus terreus isolate enhancing disease resisance and use thereof | |
KR102207732B1 (en) | Microbial agent for control of Plutella xylostella larva using Metarhizium anisopliae FT319 and its culture media | |
KR100876431B1 (en) | Streptomyces sp. MB121 strain, and a plant disease control agent containing the same | |
KR101905058B1 (en) | Bacillus amyloliquefaciens strain AK-0 and microbial agent for prevention of ginseng root rot pathogens comprising the same | |
WO2020069436A1 (en) | Methods and compositions for bioprotection of potatoes from streptomyces scabies | |
KR101232636B1 (en) | Xylogone ganodermophthora having antifungal activity and composition for preventing plant disease comprising it | |
KR102574692B1 (en) | New microorganism Bacillus velezensis CMML21-47 or microbial agent comprising the same | |
Wei et al. | Synergistic effect of photosynthetic bacteria and isolated bacteria in their antifungal activities against root rot fungi | |
KR20230087727A (en) | New strain Enterobacter oligotrophica BC01 to control of leaf spot disease | |
KR100597317B1 (en) | A Novel Streptomyces sp. and Biopesticide Containing the Strain for Extermination of Anthracnose | |
KR100597319B1 (en) | A Novel Streptomyces sp. and Biopesticide Containing the Strain for Extermination of Rice Blast Disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |